The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2025 | How the management of CML is evolving & future directions
Mhairi Copland, MB ChB, PhD, University of Glasgow, Glasgow, UK, briefly discusses the evolving management of chronic myeloid leukemia (CML), highlighting the recent publication of the ELN 2025 guidelines, the development of newer BCR-ABL-specific TKIs, and the potential of co-targeting. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
